Member Info for LTbeliever

ALB,
I'm sure the investors who put in $14mln 2 years ago and own the majority of shares, are aware of these matters; they invested not for the $30mln current value, but for the huge value there is underground.
I cannot predict the future but I expect things to move quickly in the last 2 weeks of March; the SP response will tell us if this is in the right direction.

Thanks ALB, always good to see your numbers.
From the below analysis, it seems that the Co spent about $500k on admin / salaries over H2 2022; the rest was for the Kola exploration/study expenses etc. (non-recurring).
This leaves around $4ml now (which suffice, IF the EPC is announced soon).
"31 Dec - The Company invested US$1,087,000 in exploration in the Quarter, which comprised US$ 729,000 related to the Kola Study and US$358,000 for the DX DFS Study. The Company ended the Quarter with US$5.0 million in cash."
"30 Sept - The Company invested US$ 999,000 in exploration in the Quarter, which comprised US$ 931,000 related to the Kola Study and US$ 68,000 for the DX DFS Study. The Company ended the Quarter with US$ 6.2 million in cash."

We know that funds probably need to be raised in 2023; question is when, for what purpose, how much and on what terms.
1. Existing inst. s/holders will invest; plenty of value for the taking on both Kola and DX projects;
2. In April 2021 (last fund raise) $12.6mln was raised at 1.1p and most of it was spent on exploration and study costs; the SP first rose to 1.75, then fell to 0.75, then rose again (mostly affected by news about Kola).
3. best scenario - EPC is soon announced, SP shoots up and funds are raised with minimal dilution (eg SP ends up around 6-8p);
4. worst scenario - EPC saga drags on, so Co mothballs all activity; quarterly costs remain at $200k-250k per Quarter, so $1m is needed for rest of 2023; will the Co raise funds? For what purpose? Brad could hold on a bit longer.
5. Mkt cap now at $30mln; if it has to raise eg $5m (on proviso that EPC will conclude soon, otherwise why raise 5mln and not less?), that's a 16% dilution - say 30% to make it attractive to the funders; will the SP drop to 0.60p? Or will it jump because the funds are raised because of an imminent deal with SEPCO etc?
I don't know, is the short answer; but, barring a license revocation (biggest risk), I think the downside risk Vs the upside potential probably warrants a decision to wait a few more weeks (The Co should give an update with the Y/E 2022 Results, possibly in 3 weeks).
DYOR, GL to holders.

Although the past is no guide to the future, for the past 2 years we have had the Annual Results announced on the 31 March, and within a few days after this, an additional RNS on Kola.
Will history be repeated??

So I guess whoever whispered to you, in the end was BStng you?
Or maybe, you us?
Which of the 2?

Logic would dictate that he didn't because he was a NED appointed by one of the shareholders, not a NED appointed by the Co itself; plus, he was a NED for a brief period and had he bought any shares, it would be a small holding.
Lastly, he is/was NED probably in various entities so why buy lots of shares in each entity he is appointed?
All IMO

Sol, give it a few weeks and it will get there; it's just a matter of When now, not If. IMO

Zak Mir -- he just analysed the technical situation, IF it closes around 0.045 today, could be headed to 0.08 in 1-2 months (which is when results are due); very logical conclusion, given the current undervaluation.

https://www.share-talk.com/traders-cafe-with-zak-mir-bulletin-board-heroes-friday-10th-march-2023/

it's a sign of how quickly (IMO) the SP could rise when we finally get 1-2 RNSs with good numbers/news.
People have been burned so many times that are too scared to take even a small risk; If just 50 PIs averaged down, buying 2mln shares each (800 quid or so), that's half of Helium's holding, for example.
Good luck to all holders, be patient for another 2 months (to Y/E 2022 results).

I wonder what BS he will tell people; SP rose because we bought against the trend of the market, so caught the MM off guard (and Helium).

we'll talk later, when Helium starts selling :)))

Nice!
I think the game changer will be Labskin (sorry for repeating myself), which relates to Digital Health and "GP at your home" (remember that?).
"Platform in Human and Environmental Health real-time moniroting"
Labskin paid MSYS 1.000.000 in 2022 for services relating to a new product, but on the DVRG side we have not yet seen anything about that - am I right?

tnx for confirming NU;
So, in June 2022, GJB said that H2 22 orders were already above 900k (having in mind the 600k & 200k announced by RNS a few weeks later); we also have the Services provided, which is a recurring income (but too small an amount to merit an RNS) to various clients; plus, Kingfield, which may or may not generate income in H2 022; so, is there any doubt that the Revenues for H2 022 will be at least 1 million? Thus, 650-700k Gross profit Vs oper exps of max 1 mln?
And if MSYS collected some of the 600k owed to it by DVRG in June 2022, that could mean very little cash outflow in H2 2022; that's why I said before that MSYS will have at least 2 mln Cash left at Y/E 22.
Any flaws in my logic?

Re pos. newsflow, if not mistaken, GJB was saying in the presentation (30 June) that H2 Orders were already higher than whole 2022 (i.e. were at 900k even in June 2022).
Unless I misheard him?

People were buying - 2 years ago - at 0.20-0.25, when profitability was 2 years away.
Now, the year of profitability, people hesitate to buy at 0.04, despite Revenues of 735k in H1, announced sales of 800k in H2, and probably another 600k in H1 2023 (from the 6mln pending order of DVRG in Central Asia, which was for a 100 monitoring units).
Crazy?

I think Helium will sell into any strength, which is not bad, as it gets them sooner below the 3%, then 2%, then 1%.

Once people get over their fear i.e. that the SP is still going down, they will start buying again; maybe not today but in April-May when numbers are out. IMO
GLA!

I'm not worried about Helium any more, they have a few days' worth of stock to sell ONCE results are released and the Market wakes up to the turnaround going on right under its nose.
Once Helium is out of the way, you are looking at the SP going back to 0.10 by summer.

Fwiw, I just bought another 5.5. mln shares; preparing for the turnaround.

NU,
I guess China is on the back burner for now; but the elephant in the room - IMO - is Labskin.
https://www.lse.co.uk/rns/MSYS/manufacturing-services-framework-agreement-tu8ssh0ugmvrldy.html
https://www.lse.co.uk/rns/MSYS/replacement-trading-update-ur2ekzeb6q0a4nw.html
"The outlook for the second half includes a further statement of work from DeepVerge plc's subsidiary, Innovenn UK Limited, under the previously announced Manufacturing Services Framework Agreement ("MSFA") between the same parties (the "Further Order"). This contract has a value of approximately £600,000..."
£400k for new services in H1 2022; and £600k in H2 2022; that's 1 million sales, to Labskin alone.
Note that Deepverge has not yet announced something "big" for Labskin, meaning that the big sales' news are still to come.
DYOR

I have the same feeling NU, especially given this long hiatus with no news; but I'd rather get a few meaningful RNSs per annum, with a big impact, than constant but meaningless "noise" on Twitter etc; that's a lesson well learned by GJB, IMO.

NU,
MSYS (with/without DVRG) will have a hand in huge global trends, such as
Carbon capture, water monitoring, epidemiology, pollution detection, fighting water scarcity, which will all get worse due to climate change and population growth;
If the results / outlook in the next few weeks show - IMO - that MSYS has finally turned the corner (financially) then the next 2-3 years will be hugely exciting.